Edit
Galvanize Therapeutics, Inc.
https://www.galvanizetx.com/Last activity: 07.09.2025
Probably Closed
Location: United States
Total raised: $100M
Investors 1
| Date | Name | Website |
| - | Apple Tree... | appletreep... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.09.2025 | Series C | $100M | Janus Hend... |
Mentions in press and media 15
| Date | Title | Description |
| 07.09.2025 | Galvanize Therapeutics Secures $100M: Revolutionizing Oncology and Chronic Lung Disease Treatment | Galvanize Therapeutics landed a significant $100 million Series C financing. This substantial capital propels its innovative pulsed electric field (PEF) therapies. The Redwood City firm targets critical unmet needs in oncology and chronic l... |
| 03.09.2025 | Galvanize Therapeutics Raises $100M in Series C Financing | Galvanize Therapeutics, Redwood City, CA-based commercial-stage medical technology company advancing pulsed electric field (PEF) therapies for oncology and chronic lung disease, raised a $100m Series C financing. The round was led by Sofinn... |
| 03.09.2025 | Galvanize Therapeutics Raises $100 Million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease | Sofinnova Partners leads premier investor syndicate backing Galvanize's breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach targeting solid tumors and chronic bronchitis, the leading cause of COPD. REDWO... |
| 06.08.2024 | Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung | REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed enrollment in the AFFINITY study evaluating Aliya... |
| 06.08.2024 | Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung | REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed enrollment in the AFFINITY study evaluating Aliya... |
| 06.11.2023 | Galvanize Therapeutics Announces Promising Data on the Aliya™ Pulsed Electric Field (PEF) System in Early-Stage Non-Small Cell Lung Cancer | SAN DIEGO, Nov. 6, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies, unveiled compelling data from the INCITE-ES clinical study at the recent Society for Immunotherapy for Cancer (SIT... |
| 20.09.2023 | Galvanize Therapeutics Begins U.S. Clinical Study Using Aliya™ Pulsed Electric Field (PEF) for Stage IV Non-Small Cell Lung Cancer or Metastasis to the Lung | First patient treated in the U.S. with Aliya PEF delivered via an endobronchial approach with robotic-assisted navigation REDWOOD CITY, Calif. , Sept. 20, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc. today announced the treatment of t... |
| 19.06.2023 | Galvanize Therapeutics Completes Enrollment in Pivotal Trial of RheOx® System for Chronic Bronchitis | REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field (PEF) therapies for COPD, soft tissue, and cardiac arrhythmias, has completed enrollment in the RheSolve pivotal ... |
| 19.06.2023 | Galvanize Therapeutics Completes Enrollment in Pivotal Trial of RheOx® System for Chronic Bronchitis | REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field (PEF) therapies for COPD, soft tissue, and cardiac arrhythmias, has completed enrollment in the RheSolve pivotal ... |
| 30.05.2023 | Galvanize Announces License Agreement and Partnership with Energenx Medical for its Technologies in China | License will maximize the availability of Pulsed Electric Field therapies for the population Energenx has obtained Green Channel approval for RheOx, Galvanize's proprietary Pulsed Electric Field (PEF) system for the treatment of Chronic Br... |
Show more